Endogenous glucocorticoids improve myelination via schwann cells after peripheral nerve injury: An in vivo study using a crush injury model

GLIA

Volumn 58, Issue 8, 2010, Pages 954-963

  Morisaki, Shinsuke ^a   Nishi, Mayumi ^b   Fujiwara, Hiroyoshi ^a   Oda, Ryo ^a   Kawata, Mitsuhiro ^a   Kubo, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Adrenalectomy; Corticosterone; GR; Peripheral nerve injury; Schwann cell

Indexed keywords

ACTIN; CORTICOSTERONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; MYELIN BASIC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARPAL TUNNEL SYNDROME; CELL NUCLEUS; CELL STRUCTURE; CONTROLLED STUDY; CRUSH TRAUMA; GENE EXPRESSION; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MYELINATION; NEUROMODULATION; NONHUMAN; PERIPHERAL NERVE INJURY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHWANN CELL; SCIATIC NERVE;

ADRENALECTOMY; ANALYSIS OF VARIANCE; ANIMALS; CORTICOSTERONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; INDOLES; MALE; MYELIN BASIC PROTEINS; MYELIN P0 PROTEIN; NERVE CRUSH; NERVE REGENERATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; S100 PROTEINS; SCHWANN CELLS; SCIATIC NEUROPATHY;

EID: 77952575823     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20977     Document Type: Article

References (41)

1. Abraham IM, Harkany T, Horvath KM, Luiten PG. 2001. Action of glucocorticoids on survival of nerve cells: Promoting neurodegeneration or neuroprotection? J Neuroendocrinol 13:749-760.
2. Boivin A, Pineau I, Barrette B, Filali M, Vallieres N, Rivest S, Lacroix S. 2007. Toll-like receptor signaling is critical for Wallerian degeneration and functional recovery after peripheral nerve injury. J Neurosci 27:12565-12576.
3. Chadi G, Silva C, Maximino JR, Fuxe K, da Silva GO. 2008. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDAinduced dopamine degeneration in regions of the ventral midbrain. Brain Res 1190:23-38.
4. Chan JR, Phillips LJ, 2nd, Glaser M. 1998. Glucocorticoids and progestins signal the initiation and enhance the rate of myelin formation. Proc Natl Acad Sci USA 95:10459-10464.
5. Dammers JW, Roos Y, Veering MM, Vermeulen M. 2006. Injection with methylprednisolone in patients with the carpal tunnel syndrome: A randomised double blind trial testing three different doses. J Neurol 253:574-577.
6. Demestre M, Wells GM, Miller KM, Smith KJ, Hughes RA, Gearing AJ, Gregson NA. 2004. Characterisation of matrix metalloproteinases and the effects of a broad-spectrum inhibitor (BB-1101) in peripheral nerve regeneration. Neuroscience 124:767-779.
7. Desarnaud F, Bidichandani S, Patel PI, Baulieu EE, Schumacher M. 2000. Glucocorticosteroids stimulate the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. Brain Res 865:12-16.
8. Funakoshi H, Frisen J, Barbany G, Timmusk T, Zachrisson O, Verge VM, Persson H. 1993. Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve. J Cell Biol 123:455-465.
9. Groyer G, Eychenne B, Girard C, Rajkowski K, Schumacher M, Cadepond F. 2006. Expression and functional state of the corticosteroid receptors and 11 beta-hydroxysteroid dehydrogenase type 2 in Schwann cells. Endocrinology 147:4339-4350.
10. Heinen A, Kremer D, Gottle P, Kruse F, Hasse B, Lehmann H, Hartung HP, Kury P. 2008. The cyclin-dependent kinase inhibitor p57kip2 is a negative regulator of Schwann cell differentiation and in vitro myelination. Proc Natl Acad Sci USA 105:8748-8753.
11. Hirahara Y, Matsuda K, Gao W, Arvanitis DN, Kawata M, Boggs JM. 2009. The localization and non-genomic function of the membraneassociated estrogen receptor in oligodendrocytes. Glia 57:153-165.
12. Hirakawa H, Okajima S, Nagaoka T, Takamatsu T, Oyamada M. 2003. Loss and recovery of the blood-nerve barrier in the rat sciatic nerve after crush injury are associated with expression of intercellular junctional proteins. Exp Cell Res 284:196-210.
13. Jung-Testas I, Baulieu EE. 1998. Steroid hormone receptors and steroid action in rat glial cells of the central and peripheral nervous system. J Steroid Biochem Mol Biol 65:243-251.
14. Jung-Testas I, Renoir M, Bugnard H, Greene GL, Baulieu EE. 1992. Demonstration of steroid hormone receptors and steroid action in primary cultures of rat glial cells. J Steroid Biochem Mol Biol 41:621-631.
15. Kobayashi H, Kambe F, Imai T, Hibi Y, Kikumori T, Ohmori S, Nakao A, Seo H. 2006. Differential expression of cyclin-dependent kinase inhibitors, p27Kip1 and p57Kip2, by corticotropin in rat adrenal cortex. J Endocrinol 189:671-679.
16. LeBlanc AC, Poduslo JF. 1990. Axonal modulation of myelin gene expression in the peripheral nerve. J Neurosci Res 3:317-326.
17. Lee JH, An JH, Lee SH, Hwang EY. 2009. Effectiveness of steroid injection in treating patients with moderate and severe degree of carpal tunnel syndrome measured by clinical and electrodiagnostic assessment. Clin J Pain 25:111-115.
18. Lee JM, Yan P, Xiao Q, Chen S, Lee KY, Hsu CY, Xu J. 2008. Methylprednisolone protects oligodendrocytes but not neurons after spinal cord injury. J Neurosci 28:3141-3149.
19. Magnaghi V, Cavarretta I, Galbiati M, Martini L, Melcangi RC. 2001. Neuroactive steroids and peripheral myelin proteins. Brain Res Brain Res Rev 37:360-371.
20. Makara GB, Haller J. 2001. Non-genomic effects of glucocorticoids in the neural system. Evidence, mechanisms and implications. Prog Neurobiol 65:367-390.
21. Martini R, Fischer S, Lopez-Vales R, David S. 2008. Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease. Glia 56:1566-1577.
22. Melcangi RC, Magnaghi V, Cavarretta I, Riva MA, Martini L. 1997. Corticosteroid effects on gene expression of myelin basic protein in oligodendrocytes and of glial fibrillary acidic protein in type 1 astrocytes. J Neuroendocrinol 9:729-733.
23. Melcangi RC, Magnaghi V, Galbiati M, Ghelarducci B, Sebastiani L, Martini L. 2000. The action of steroid hormones on peripheral myelin proteins: A possible new tool for the rebuilding of myelin? J Neurocytol 29:327-339.
24. Meyer M, Matsuoka I, Wetmore C, Olson L, Thoenen H. 1992. Enhanced synthesis of brain-derived neurotrophic factor in the lesioned peripheral nerve: Different mechanisms are responsible for the regulation of BDNF and NGF mRNA. J Cell Biol 119:45-54.
25. Mirsky R, Jessen KR. 1999. The neurobiology of Schwann cells. Brain Pathol 9:293-311.
26. Mitchell LS, Griffiths IR, Morrison S, Barrie JA, Kirkham D, McPhilemy K. 1990. Expression of myelin protein gene transcripts by Schwann cells of regenerating nerve. J Neurosci Res 27:125-135.
27. Morimoto M, Morita N, Ozawa H, Yokoyama K, Kawata M. 1996. Distribution of glucocorticoid receptor immunoreactivity and mRNA in the rat brain: An immunohistochemical and in situ hybridization study. Neurosci Res 26:235-269.
28. Neuberger TJ, Kalimi O, Regelson W, Kalimi M, De Vries GH. 1994. Glucocorticoids enhance the potency of Schwann cell mitogens. J Neurosci Res 38:300-313.
29. Ng BK, Chen L, Mandemakers W, Cosgaya JM, Chan JR. 2007. Anterograde transport and secretion of brain-derived neurotrophic factor along sensory axons promote Schwann cell myelination. J Neurosci 27:7597-7603.
30. Nishi M, Tanaka M, Matsuda K, Sunaguchi M, Kawata M. 2004. Visualization of glucocorticoid receptor and mineralocorticoid receptor interactions in living cells with GFP-based fluorescence resonance energy transfer. J Neurosci 24:4918-4927.
31. Nishi M, Usuku T, Itose M, Fujikawa K, Hosokawa K, Matsuda KI, Kawata M. 2007. Direct visualization of glucocorticoid receptor positive cells in the hippocampal regions using green fluorescent protein transgenic mice. Neuroscience 146:1555-1560.
32. Ribeiro-Resende VT, Oliveira-Silva A, Ouverney-Brandao S, Santiago MF, Hedin-Pereira C, Mendez-Otero R. 2007. Ganglioside 9-O-acetyl GD3 expression is upregulated in the regenerating peripheral nerve. Neuroscience 147:97-105.
33. Roglio I, Bianchi R, Gotti S, Scurati S, Giatti S, Pesaresi M, Caruso D, Panzica GC, Melcangi RC. 2008. Neuroprotective effects of dihydroprogesterone and progesterone in an experimental model of nerve crush injury. Neuroscience 155:673-685.
34. Sherman DL, Brophy PJ. 2005. Mechanisms of axon ensheathment and myelin growth. Nat Rev Neurosci 6:683-690.
35. Song XY, Zhou FH, Zhong JH, Wu LL, Zhou XF. 2006. Knockout of p75(NTR) impairs re-myelination of injured sciatic nerve in mice. J Neurochem 96:833-842.
36. Stahn C, Lowenberg M, Hommes DW, Buttgereit F. 2007. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol 275:71-78.
37. Sternberg EM. 2006. Neural regulation of innate immunity: A coordinated nonspecific host response to pathogens. Nat Rev Immunol 6:318-328.
38. Tasker JG, Di S, Malcher-Lopes R. 2006. Minireview: Rapid glucocorticoid signaling via membrane-associated receptors. Endocrinology 147:5549-5556.
39. Tomita K, Kubo T, Matsuda K, Fujiwara T, Yano K, Winograd JM, Tohyama M, Hosokawa K. 2007. The neurotrophin receptor p75NTR in Schwann cells is implicated in remyelination and motor recovery after peripheral nerve injury. Glia 55:1199-1208.
40. Vardimon L, Ben-Dror I, Avisar N, Oren A, Shiftan L. 1999. Glucocorticoid control of glial gene expression. J Neurobiol 40:513-527.
41. Xu W, Manichella D, Jiang H, Vallat JM, Lilien J, Baron P, Scarlato G, Kamholz J, Shy ME. 2000. Absence of P0 leads to the dysregulation of myelin gene expression and myelin morphogenesis. J Neurosci Res 60:714-724.